124 related articles for article (PubMed ID: 29999571)
1. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.
Jiang Y; Liu Z; Xu F; Dong X; Cheng Y; Hu Y; Gao T; Liu J; Yang L; Jia X; Qian H; Wen T; An G
J Cell Mol Med; 2018 Oct; 22(10):4875-4885. PubMed ID: 29999571
[TBL] [Abstract][Full Text] [Related]
2. Tn antigen promotes breast cancer metastasis via impairment of CASC4.
Li R; Dong X; Chen S; Tan J; Chen X; Liu J; Wen T; Ru X
Cell Biol Int; 2023 Nov; 47(11):1854-1867. PubMed ID: 37493437
[TBL] [Abstract][Full Text] [Related]
3. The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.
Ho CW; Lin CY; Liaw YW; Chiang HL; Chin YT; Huang RL; Lai HC; Hsu YW; Kuo PJ; Chen CE; Lin HY; Whang-Peng J; Nieh S; Fu E; Liu LF; Hwang J
Oncotarget; 2016 Sep; 7(38):61930-61944. PubMed ID: 27542280
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-screen identifies ZIP9 and dysregulated Zn2+ homeostasis as a cause of cancer-associated changes in glycosylation.
Rømer TB; Khoder-Agha F; Aasted MKM; de Haan N; Horn S; Dylander A; Zhang T; Pallesen EMH; Dabelsteen S; Wuhrer M; Høgsbro CF; Thomsen EA; Mikkelsen JG; Wandall HH
Glycobiology; 2023 Oct; 33(9):700-714. PubMed ID: 36648436
[TBL] [Abstract][Full Text] [Related]
5. Germline
Erger F; Aryal RP; Reusch B; Matsumoto Y; Meyer R; Zeng J; Knopp C; Noel M; Muerner L; Wenzel A; Kohl S; Tschernoster N; Rappl G; Rouvet I; Schröder-Braunstein J; Seibert FS; Thiele H; Häusler MG; Weber LT; Büttner-Herold M; Elbracht M; Cummings SF; Altmüller J; Habbig S; Cummings RD; Beck BB
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2211087120. PubMed ID: 37216524
[TBL] [Abstract][Full Text] [Related]
6. A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion.
Valoskova K; Biebl J; Roblek M; Emtenani S; Gyoergy A; Misova M; Ratheesh A; Reis-Rodrigues P; Shkarina K; Larsen ISB; Vakhrushev SY; Clausen H; Siekhaus DE
Elife; 2019 Mar; 8():. PubMed ID: 30910009
[TBL] [Abstract][Full Text] [Related]
7. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis.
Xie B; Zhang M; Li J; Cui J; Zhang P; Liu F; Wu Y; Deng W; Ma J; Li X; Pan B; Zhang B; Zhang H; Luo A; Xu Y; Li M; Pu Y
Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2314128121. PubMed ID: 38359291
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance related to aberrant glycosylation in colorectal cancer.
Very N; Lefebvre T; El Yazidi-Belkoura I
Oncotarget; 2018 Jan; 9(1):1380-1402. PubMed ID: 29416702
[TBL] [Abstract][Full Text] [Related]
9. Cosmc overexpression enhances malignancies in human colon cancer.
Gao T; Du T; Hu X; Dong X; Li L; Wang Y; Liu J; Liu L; Gu T; Wen T
J Cell Mol Med; 2020 Jan; 24(1):362-370. PubMed ID: 31633299
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
Sun X; Ju T; Cummings RD
BMC Cancer; 2018 Aug; 18(1):827. PubMed ID: 30115016
[TBL] [Abstract][Full Text] [Related]
11. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation.
Liu Z; Liu J; Dong X; Hu X; Jiang Y; Li L; Du T; Yang L; Wen T; An G; Feng G
J Cell Mol Med; 2019 Mar; 23(3):2083-2092. PubMed ID: 30637914
[TBL] [Abstract][Full Text] [Related]
12. Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn
Hu W; Ding R; Wang M; Huang P; Wei X; Hu X; Hu T
Stem Cell Res Ther; 2023 May; 14(1):145. PubMed ID: 37237420
[TBL] [Abstract][Full Text] [Related]
13. Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease.
Xiang T; Qiao M; Xie J; Li Z; Xie H
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551160
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of Tn antigen expression in colorectal adenocarcinoma and precursor lesions.
Dombek GE; Ore AS; Cheng J; Matsumoto Y; Glickman JN; Fleishman A; Heimburg-Molinaro J; Poylin VY; Fabrizio A; Cataldo T; Messaris E; Cummings RD
BMC Cancer; 2022 Dec; 22(1):1281. PubMed ID: 36476111
[TBL] [Abstract][Full Text] [Related]
15. The role of O-glycosylation in human disease.
Magalhães A; Duarte HO; Reis CA
Mol Aspects Med; 2021 Jun; 79():100964. PubMed ID: 33775405
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression.
Tian H; Yu JL; Chu X; Guan Q; Liu J; Liu Y
Front Oncol; 2024; 14():1389713. PubMed ID: 38699634
[TBL] [Abstract][Full Text] [Related]
17. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.
Chen Y; Ji Y; Shen L; Li Y; Ren Y; Shi H; Li Y; Wu Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):214. PubMed ID: 38662050
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation: A Crucial Regulator in Cancer-Associated Biological Events.
Ran Z; Zhang L; Dong M; Zhang Y; Chen L; Song Q
Cell Biochem Biophys; 2023 Sep; 81(3):383-394. PubMed ID: 37392316
[TBL] [Abstract][Full Text] [Related]
19. Deciphering Protein O-GalNAcylation: Method Development and Disease Implication.
Yue S; Wang X; Ge W; Li J; Yang C; Zhou Z; Zhang P; Yang X; Xiao W; Yang S
ACS Omega; 2023 Jun; 8(22):19223-19236. PubMed ID: 37305274
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
